If this is real science -- why is an American biotech conducting trials in foreign countries? Even if the results are validated there will not be a fast track by the US FDA.
Remember Dimebon -- flying high in Phase I-II in Russia then falling hard under scrunity when Phase III involved US sites.
"Research was conducted in both Russia and western nations into potential applications as a neuroprotective drug to treat Alzheimer's disease and, possibly, as a nootropic, as well. After a major phase III clinical trial for Alzheimer's disease (AD) treatment failed to show any benefit, three other AD trials continued. Major industry-based development in this indication essentially stopped after another Phase III trial suffered the same fate in 2012. Dimebon failed in the phase III trial for Huntington disease."
And the Chinese communists pumped in 30 BILLIONS to manipulate their stock market.
UVXY will be forced down again -- as it was on Thu 07/02 -- there were "good" news about a last minute deal everywhere when indeed there was none.